Docusign at 3.2x guided sales: IAM has to make the 9.8% cash yield real

Allan Thygesen presents Docusign's agreement-AI strategy at Momentum London on July 1, 2026. The company-issued event photograph shows the product transition behind the valuation debate; it is not evidence of quarterly adoption or financial performance.[5]

Priced: at the September 11 close of $65.65, Docusign carried an enterprise value of roughly 3.2 times the midpoint of its fiscal 2027 revenue guide and an equity free-cash-flow yield of about 9.8% on the trailing 12 months.[1][2][3][4] New: Intelligent Agreement Management, or IAM, jumped from 12.6% to 15.1% of total annual recurring revenue in one quarter, yet management still guides the whole ARR base to only 8.5%–9.0% growth for the year.[1]

That is an appealing multiple attached to an unfinished transition. The market is no longer valuing Docusign as a pandemic-era hypergrowth asset; it is valuing a mature subscription company that generates cash, retires shares and may have found a second product engine. The catch is that IAM's share can rise while the company merely moves existing eSignature customers into a broader package. A durable rerating needs the new platform to accelerate the total recurring-revenue pool—not just occupy more of it.

Evidence cut-off: September 11, 2026 at 22:35 UTC. Valuation figures are author calculations using Docusign's August 31 share count, July 31 cash and investments, the September 11 closing price and company-reported cash flow. Ratios are approximate, free cash flow is a company-defined non-GAAP liquidity measure, and the stock-based-compensation sensitivity below is not an accounting forecast. This is analysis, not a recommendation to buy or sell the shares.[1][2][3][4]

Image context: the cover is Docusign's real event photograph of CEO Allan Thygesen speaking at Momentum London in July 2026, where the company presented its Iris assistant and contract agents. It grounds the product claim in an actual company event without pretending that a keynote proves revenue, retention or valuation.[5]

Start with the share count, not a quote-screen multiple

Docusign had 186.9 million shares outstanding on August 31.[2] Multiplying that count by the September 11 close produces an equity value near $12.27 billion. The July quarter ended with $973.1 million of cash, cash equivalents and investments, and the revolving credit facility was undrawn.[1][2] Subtracting that liquid balance gives an approximate enterprise value of $11.30 billion.

That 186.9 million figure is a point-in-time basic count; the Q2 period-average diluted count was 193.1 million.[2] Substituting the larger denominator would put enterprise value at about 3.34x guided sales and the equity free-cash-flow yield near 9.45%. The point-in-time count is the closer filed denominator for a spot valuation, but matching August shares, July cash and a September price still makes this a bridge, not a live balance sheet.

Management's fiscal 2027 revenue range is $3.499 billion–$3.507 billion. The $3.503 billion midpoint therefore puts the shares at about 3.23x enterprise value to guided sales.[1] That is not a demanding sales multiple for a subscription business with an 81%-plus non-GAAP gross margin. It also does not say how much of those sales belongs to a growing platform rather than a well-defended eSignature base.

The cash multiple looks cheaper. Fiscal 2026 free cash flow was $1.059 billion.[3] For the trailing 12 months through July 2026, replace the first half of that fiscal year with the latest first half: subtract $445.5 million and add $585.2 million, each calculated as operating cash flow less purchases of property and equipment.[2][3] The result is approximately $1.198 billion, or 10.2x equity value and a 9.8% yield.

This is the attractive part of the setup. Revenue is still rising at a high-single-digit rate, the balance sheet has net cash, and the equity trades near ten times a cash measure that already deducts capital expenditure. Docusign does not need to recover an old software multiple for holders to receive value; it needs to protect the cash stream and avoid paying too much to keep its share count under control.

The 9.8% yield has an equity bill inside it

Free cash flow treats stock-based compensation as non-cash. Shareholders cannot stop there, because the awards transfer part of the company to employees unless repurchases offset them.

Docusign recorded about $606 million of expensed stock-based compensation over the same trailing period used for the free-cash-flow calculation, and capitalized roughly $64 million more in internal-use software.[2][3] Subtracting the expensed amount alone would leave roughly $592 million, an implied owner yield of 4.8%; subtracting both amounts would leave about $529 million, or 4.3%. These are deliberately conservative sensitivities, not official metrics: grant-date expense is not identical to the cash salary that would replace an award, and share-price changes alter the eventual dilution. But they show why the headline 9.8% should not be treated as coupon-like cash.

The buyback record supplies the other side of the ledger. Docusign spent roughly $1.11 billion on repurchases over the trailing 12 months—about 93% of free cash flow by the same reconstruction.[2][3] This was more than cosmetic dilution control. Shares outstanding fell from 197.8 million at January 31 to 186.9 million at August 31, a decline of about 5.5%, even after employee awards vested.[2]

That reduction creates real per-share value at a sensible purchase price. It also consumes nearly all the cash the business produces. At July 31, Docusign still had 28.0 million unvested restricted-stock units and $1.2 billion of unrecognized RSU compensation expected over about 2.4 years.[2] The remaining $2.1 billion repurchase authorization is capacity, not free funding. If repurchases continue above free cash flow, the net-cash cushion eventually pays the difference.

The valuation therefore needs more than one cash lens. The reported cash view says 9.8%; the fully burdened stock-compensation sensitivity says 4.3%. Neither is a proven bound on economic yield. The outcome depends on future award grants, vesting, the price paid for repurchases and whether the share count keeps falling. Docusign has so far earned credit for the last item. It has not made the equity bill disappear.

IAM is expanding faster than Docusign

The product transition is visible. IAM represented 10.8% of total ARR at January 31, 12.6% at April 30 and 15.1% at July 31. Management now expects the platform to exit fiscal Q4 at 18%–19% of total ARR.[1][3] The July event photograph makes the strategy tangible: Docusign is presenting Iris, agreement review, approval agents and custom workflows as a wider operating layer, not merely a signature button.[5]

Put dollars around those percentages, illustratively. Fiscal 2026 reported total ARR of $3.272 billion and a 10.8% IAM mix imply roughly $353 million of IAM ARR and $2.919 billion outside IAM. If that same base grows at the 8.75% midpoint of the current total-ARR guide and reaches the 18.5% midpoint of the IAM exit-mix target, the result is about $3.558 billion of total ARR, $658 million inside IAM and $2.900 billion outside it. At those two midpoints, the non-IAM remainder is roughly 0.6% smaller on a common base. Docusign resets its fixed ARR exchange rate annually and retranslates prior figures, so the dollar bridge ignores any rebasing; it is scenario math, not a management segment forecast. Management said most IAM ARR comes from the installed base and that expansion has been meaningful, but it does not disclose the expansion rate.[1][3][6]

The financial handoff remains less dramatic. Q2 revenue grew 9% to $875.7 million, but foreign exchange supplied about 1.3 percentage points of that increase. The $3.503 billion full-year revenue midpoint is 8.8% above fiscal 2026 revenue; subtracting the company's estimated 1.2-percentage-point currency benefit leaves roughly 7.6% underlying growth. Total ARR is guided to 8.5%–9.0% growth.[1][3]

Rapid IAM adoption can coexist with moderate consolidated growth for three different reasons. Existing customers may be migrating contract value from standalone products into IAM; IAM may be upselling the installed base while slower legacy lines offset it; or the platform may be adding genuinely new workloads that have not yet become large enough to move consolidated growth. Only the third path clearly supports a higher growth multiple. The first two can still defend cash flow, but they describe mix improvement rather than company-wide acceleration.

The distinction matters because management has already supplied a destination for the mix. Reaching 18%–19% of ARR would show execution against the product roadmap. It would not, by itself, show that Docusign's total ARR is expanding faster. Investors need both the numerator and the denominator.

Margin expansion is real, but capitalization deserves a footnote

The strongest counterweight to the growth caution is operating leverage. Q2 free-cash-flow margin reached 34%, up from 27% a year earlier, while GAAP operating income rose to $117.6 million from $65.2 million.[1][2] Sales and marketing fell from 38% to 36% of revenue, and research and development fell from 21% to 19%.[2] This is what a mature subscription franchise is supposed to do: turn moderate growth into faster cash and per-share progress.

One accounting movement makes the improvement less automatic. Docusign capitalized $97.5 million of software-development costs in the first half, up from $65.1 million a year earlier. The filing says the decline in research-and-development expense partly reflected that higher capitalization.[2] Cash purchases of property and equipment are deducted in free cash flow, so the investment is not simply ignored there. Still, capitalization shifts expense recognition into later periods and makes current operating margins look better. The margin case should be judged across both the income statement and the cash-flow statement.

Cash conversion also benefited from working-capital movement. In the first half, accounts receivable released $142.8 million of cash while contract liabilities used $55.1 million.[2] Neither move invalidates the $585.2 million first-half free-cash-flow result, but both warn against annualizing one clean half without checking renewal timing. The trailing calculation is a better anchor than doubling Q2; it is still a rear-view measure.

Falsifier

The cautious thesis—that Docusign deserves only a modest multiple until IAM lifts consolidated growth—is falsified if fiscal 2027 ends with total ARR growth above 10% while the share count continues to decline and cash plus investments remain at or above the July level. That combination would show platform mix turning into company-wide acceleration without financing per-share progress from the balance sheet. IAM reaching its mix target while total ARR stays inside the current 8.5%–9.0% guide would not clear the test.

Three dated checks

By September 30, 2026: check whether Docusign makes its Model Context Protocol server generally available on management's end-of-month timetable. Management said an existing Docusign customer downloading a connector does not itself add revenue and that connector-led discovery is still early, so shipment matters less than evidence of new pipeline and workloads.[6]
Quarter ending October 31, 2026: compare Q3 revenue with the $886 million–$890 million guide and separate the stated currency tailwind from underlying growth. Also rebuild the cash bridge—free cash flow, repurchases, stock compensation, ending cash and the actual share count—and test whether the 31.3%–31.7% non-GAAP operating-margin guide arrives without another sharp increase in capitalized development.[1][2]
Fiscal year ending January 31, 2027: put the two ARR disclosures beside each other. IAM is targeted at 18%–19% of the total; total ARR is guided to 8.5%–9.0% growth. The valuation case strengthens only if a larger IAM numerator begins pulling up the denominator.[1]

Docusign at $65.65 is inexpensive enough to make the transition interesting, but not simple enough to reduce to a ten-times-cash slogan. At 3.2x guided sales, the market is granting little credit for a new growth engine. At a 9.8% trailing cash yield, it is also relying on a measure that treats a large equity expense as non-cash. The bridge between those two readings is IAM: not its logo on a keynote screen, and not its percentage of ARR in isolation, but its ability to lift total growth while the company keeps shrinking the share count with cash it actually earns.

cronfeed.work